Bharat Biotech International Limited is an Indian multinational biotechnology company headquartered in Hyderabad, engaged in the drug discovery, drug development, manufacture of vaccines, bio-therapeutics, pharmaceuticals and health care products. Read More
The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its COVID-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said. ...
The meeting of the Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is underway to discuss recommendations on restricted emergency use of Bharat Biotech's Covaxin and Biological E's Corbevax COVID-19 vaccine for children ...
Welcoming the decision to make precautionary dose available for all adults, Hyderabad-based vaccine manufacturer Bharat Biotech on Saturday, announced that it has revised the price of its COVID vaccine Covaxin from Rs 1,200 to Rs 225 per dose for pri ...
Hyderabad-based Bharat Biotech on Sunday issued a clarification that there is "no impact on efficacy and safety of the COVID-19 vaccine COVAXIN" after the World Health Organisation suspended it from its Covax facility. ...
Bharat Biotech on Friday announced the temporary slowing down of production of COVAXIN across its manufacturing facilities, having completed its supply obligations to procurement agencies and foreseeing the decrease in demand. ...
The 4th edition of BW Disrupt Women Entrepreneurship Summit & Awards (WESA) is an exclusive BW Businessworld property that celebrates and recognises outstanding women entrepreneurs. ...